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Whereas Chromobacterium viscosum lipase (CVL) catalyzes selectively the acylation of the C-8 
hydroxyl of the three stereoisomeric vitamin D A-ring precursors 2a, 3a and 3b, only the C-3 
hydroxyl of the fourth stereoisomer 2b is acylated under the same conditions in organic solvent. 
In a convenient application, the racemic vitamin D A-ring precursor 4, possessing only the C-5 
hydroxyl, was resolved using suitable conditions identified from the studies of 2 and 3. 
Introduction 
The metabolism of vitamin D3 (la) involves (2-25 
hydroxylation in the liver to produce 25-hydroxyvitamin 
D3 (lb) followed by C-1 hydroxylation in the kidney to 
give la,25-dihydroxyvitamin Da (IC, 1a,25-(OH)2-D3), the 
hormonally active form of vitamin D.3 In addition to its 
long known calcemic action, a number of biological 
activities including those related to cancer: skin dis- 
e a s e ~ , ~  immunomodulatory effects? and Alzheimer’s 
disease7 have been linked to this hormone. Accordingly, 
the synthesis of new analogues has drawn increasing 
attention from the standpoint of developing chemothera- 
peutically useful drugs. Substantial effort has also been 
directed toward developing cogent structure-function 
relationships to develop an improved paradigm for more 
effectively designing target analogues. For example, a 
number of A-ring carbinol diastereoisomers of la,25- 
(OH)2-D3 (IC) recently synthesized in our laborato$ 
proved highly informative in probing the structural 
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demands of the nuclear vitamin D receptor, which 
mediates the genomic effects of vitamin D. It has also 
been determined that the C-1 epimer of la,25-(OH)z-D3 
is a potent inhibitor of the nongenomic calcium transport 
actions of 1~ ,25 - (0H)~-D~ (lc),db,c,d and it has been found 
that the C-3 epimer is a natural metabolite of this same 
h~rmone .~  In addition, the synthesis of isotopically 
labeled derivatives of vitamin D3 and its metabolites has 
provided convenient research tools for evaluation of 
biosynthetic pathways as well as chemical processes (e.g., 
[1,7]-sigmatropic hydrogen shifts).1° 
A general approach leading to the synthesis of vitamin 
D analogues involves coupling of an appropriate CD-ring 
fragment and A-ring synthons such as enynes 2,3, and 
4 which have been derived from (SI- or (R)-carvone (5)8aJ1 
or hydroxy ketal 61°a (Chart 1). Recently, there emerged 
a need in our laboratory for preparing A-ring synthons 
such as 2 and 3 modified selectively at their carbinol 
centers, as well as for preparing large amounts of racemic 
and enantiomerically pure A-ring enynol4. Accordingly, 
we began an evaluation of enzymatic procedures for 
effecting these transformations. Lipases and proteases 
have been used effectively in regioselective acylation of 
natural products with various hydroxyl groups and in the 
resolution of racemic pharmacological compounds.12 Here 
we report a systematic study of the enzyme-catalyzed 
acylation in organic solvents of the four A-ring diastere- 
oisomers 2a, 2b, 3a, and 3b and the novel finding that 
the cis stereoisomer 2b is uniquely acylated at its allylic 
((2-3) hydroxyl position, just the reverse of the nonallylic 
(C-5) acylation observed for 2a, 3a, and 3b. This acyla- 
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Chart 1 
H O ' M Y  
l a ,  X= Y= H 
b, X= OH: Y= H 
C. X= Y= OH 
2 
a, R= OH; R'= H 
b, R= H; R'= OH 
3 
Table 1. Reaction of 2a with Vinyl Acetate 7a Catalyzed 
by Enzymes' 
enzyme t(h) convn(%)b 8a(%Ib 9a(%)b 
CCL 115 82 67 33 
PSL 115 85 47 53 
CVL 96 72 '95 '5 
PPL 137 < 10 trace trace 
papain 93 < 10 trace trace 
CALC 91 56 37 63 
subtilisin 71 0 
These processes were carried out at room temperature. Cal- 
Table 2. Reaction of 2a with Vinyl Esters 7a-e 
culated by 'H-NMR analysis. SP 435L. 
Catalyzed by CVLa 
V 
entry R solvent t(h) convn(%)b 8(%)b,c !I(%)* 
b, X= C(CHz)CH3; Y= H [(R)-(-)] 1 OH 
6 
v' 
4, X= H; Y= OH [(S)-(-)] 
b, X= OH: Y= H [(f?)-(+)] 
Scheme 1 
111 
RKO' k H  
8 0 Enzyme 
HO' Solvent RKO% - + 
2a 7 111 
HO' &OK, 
9 
[a, R=Me; b, R=Et; C, R=Pr; d, R=CHzCI; e, R=Ph] 
tion procedure has also been extended to an application 
to the resolution of the related racemic synthon (fl-4. 
Results and Discussion 
Acylation of 2a. The studies of enzymatic acylation 
were first focused on the A-ring fragment 2a, which 
possesses the natural carbinol stereochemistry (3S,5R).hn 
Initial experiments concerned screening lipases [Candida 
cylindracea lipase (CCL), Pseudomonas cepacia lipase 
(PSL), Chromobacterium viscosum lipase (CVL), porcine 
pancreatic lipase (PPL), and Candida antarctica lipase 
(CAL)] and proteases [subtilisin and papain] as catalysts 
to determine which enzyme gives the best regioselectivity 
for acylation (Scheme 1). For the initial studies vinyl 
acetate was used as the acetylating agent and solvent, 
and the results are summarized in Table 1. 
Of the enzymes studied, CVL gives the best result. It 
catalyzes acetylation of the C-54R) hydroxyl group with 
excellent regioselectivity and in good yield. CCL also 
revealed some preference for the same hydroxyl, but the 
selectivity is lower. When CAL or PSL was used, 
acetylation occurred with a slight preference for C-3 
instead of C-5. As one can see in Table 1, PPL and 
papain gave only trace amounts of products 8a and 9a. 
In the case of the protease subtilisin no reaction occurred 
even after long reaction times. 
a Me none 24 100 93(90) 7 
b Et none 40 100 87(90) 13 
C P r  none 96 100 84(85) 16 
d ClCHz THF 45 100 85(70) 15 
e Ph THF 113 0 
These processes were carried out at 45 "C. Calculated by lH- 
NMR analysis. c Values in parentheses represent isolated yields 
of 8. 
To more fully investigate the reaction conditions for 
this enzymatic acetylation, a variety of solvents were 
tested with two goals in mind. The first was to find the 
best enzyme-solvent system for acetylation of the C-5- 
( R )  hydroxyl group. The second goal was to find condi- 
tions, if possible, for the regioselective acylation of the 
(3S)-hydroxyl group. Of the enzyme-solvent systems 
studied, CVL in THF gave the highest regioselectivity 
toward the C-543) hydroxyl @a), but the use of vinyl 
acetate as solvent afforded better results. CAL shows 
greater selectivity (74% of 8a, 26% of 9a) toward position 
5 when the solvent is benzene. However, the opposite 
regioselectivity (39% of 8a, 61% of 9a) somewhat favoring 
the C-3 hydroxyl group is achieved when isopropyl ether 
is used as the solvent, but conditions for selective 
acylation at C-3 could not be defined. 
To evaluate other acylating agents and take advantage 
of the observation that CVL shows excellent acetylation 
selectivity and yield with vinyl acetate as solvent, the 
reaction of 2a with other vinyl esters was studied. As 
shown in Table 2, the reactions were run at  45 "C using 
a ratio of vinyl ester to diol of -1O:l.  The vinyl ester 
was used as the solvent whenever possible, but THF was 
added as solvent in those cases where the high boiling 
point of the acylating agent rendered cumbersome its 
removal from the product mixture. Acylation occurred 
selectively at the C-54R) hydroxyl except when vinyl 
benzoate was used wherein esterification did not take 
place even after heating at 45 "C for several days. 
In summary, the results indicate that CVL will allow 
regioselective incorporation of a variety of acyl moieties 
at  the C-5-(R) hydroxyl of 2a. While these results 
indicate that vinyl esters are generally suitable, acid 
anhydrides gave poor selectivity and afforded low conver- 
sion. Selective acylation at C-3 of 2a could not be 
effectively achieved. 
Acylation of the Stereoisomers of 2a: Its Enan- 
tiomer 3b and Cis Stereoisomers 3a and 2b. Table 
3 summarizes the results obtained for the acylation of 
the enantiomer of (3$,5R)-2a, namely (3R,5S)-3b8* shown 
in Scheme 2. For direct comparison to the data in Table 
2 for 2a, CVL was also used and it was determined that 
the reaction with 3b also proceeds with quantitative 
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Table 3. Reaction of 3b with Vinyl Esters 7a-e 
Catalyzed by CVLa 
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Table 4. Reaction of 3a with Vinyl Esters 7a,c-d 
8059 
Catalyzed by CVL" 
~~ 
entry R solvent t (h)  convn(%)b 10(%)bJ 1l(%lb 
a Me none 7 100 94 (88) 6 
b Et none 7 100 94(95) 6 
C P r  none 5 100 95 (70) 5 
d ClCHz THF 21 100 78(71) 22 
e Ph THF 119 100 92 (70) 8 
a These processes were carried out at room temperature. Cal- 
culated by 'H-NMR analysis. Values in parentheses represent 
isolated yields of 10. 
Scheme 2 
'I' 3b 
11 
Scheme 3 
R' &R d R' ~e~~~~fiin-R~&~-Ro&R' d 
d R 
2a, RE OH; R'= H 128, R= OH; R'= H 2b, R= OH; R'= H 
3b, R= H; R'= OH b, R- H; R'= OH 3a, R= H; R'= OH 
regioselectivity toward the hydroxyl group at the C-5 
position. The acylation reaction is however faster for 3b 
with vinyl acetate than its enantiomer 2a. Complete 
conversion of 3b with vinyl acetate at room temperature 
occurs in 7 h, while that of enantiomer 2a requires 
heating of the reaction mixture at 45 "C for 24 h (see 
entry a in Table 2 versus entry a in Table 3). The 
regioselectivities obtained with the different vinyl esters 
are somewhat higher than for 2a. Significantly, 3b 
reacts with vinyl benzoate at room temperature, which 
contrasts to the lack of reaction of enantiomer 2a under 
somewhat more forcing conditions (room temperature 
versus 45 "C). 
Tables 4 and 5 and Schemes 4 and 5 summarize 
similar acylation studies of the cis stereoisomers (3S,5S)- 
3a and (3R,5R)-2b, respectively, which were synthesized 
as shown in Scheme 3. In the latter scheme, selective 
oxidation of the C-3 allylic alcohol of 2a and 3b using 
the Dess-Martin reagent13 afforded ketones 12a and 
12b, which were reduced in a conventional fashion to the 
requisite cis diols 2b and 3a, respectively. There was 
obtained -3:l cis to trans selectivity (separable by HFLC) 
in both cases. 
As shown in Table 4, CVL-catalyzed acetylation of the 
cis diol 3a occurred with complete regioselectivity (100%) 
(13) (a) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983,48,4155. (b) 
Dess, D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277. (c) 
Ireland, R. E.; Liu, L. J. Org. Chem. 1993, 58, 2899. 
a Me none 21 100 lOO(90) 0 0 
C P r  none 48 100 98(89) 0 2 
a These processes were carried out at room temperature. Cal- 
culated by 'H-NMR analysis. c Values in parentheses represent 
isolated yields of 13. 
d ClCHz THF 23 100 93(86) 7 0 
Table 5. Reaction of 2b with Vinyl Esters 7a,c-d 
Catalyzed by CVLa 
convn 16 17 18 
entry R solvent t ( h )  (%Ib (%)b (%)b,c (%Ib 
a Me none 48 100 1 95(80) 4 
C P r  none 144 100 <2 >98(90) 0 
d ClCH2 THF 92 100 2.5 91 (85) 6.5 
a These processes were carried out at room temperature. Cal- 
culated by 'H-NMR analysis. Values in parentheses represent 
isolated yields of 17. 
Scheme 4 
0 
CVL 
HO kOH+ RKO- Solvent, r.t. * 
7 3a 
13 14 15 
[a, R=Me; c, R=Pr; d, R=CH2CI] 
Scheme 5 
111 
0 
CVL 
HO' hOH+ Solvent, r.t. - 
7 2b 
16 17 18 
[a, R=Me; c, R=Pr; d, R=CH2CI] 
toward the hydroxyl group at the C-5 position. Excellent 
results were also obtained with vinyl butyrate and vinyl 
chloroacetate (-100% and 93% regioselectivity, respec- 
tively). 
As shown in Table 5, parallel acylation of the remain- 
ing stereoisomer cis diol 2b proved most interesting 
wherein C-3 hydroxylation now dominates, just the 
opposite of its three C-3,5 stereoisomers 2a, 3a, and 3b. 
The selectivity and rate was qualitatively only slightly 
lower than that for 3a. Vinyl butyrate, used as both the 
acylating reagent and solvent, exhibited complete regio- 
selectivity toward the hydroxyl group at the C-3 position. 
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Scheme 6 
Fernhdez et al. 
had 94% ee. Thus, this route provides a convenient direct 
route to 4a possessing the natural C-5 configuration 
(corresponding to the steroidal 3p-hydroxyl) of vitamin 
D3. 
(f)-4 (S)-(-)-& (R)-(+)-19 
2 97% ee 
NaOMe I 
MeOH 1 
'I' 
From the results of the acylation of the four stereo- 
isomers 2a, 2b, 3a, and 3b, it is clear that a hydroxyl 
group with the C-5-(S) or p orientation14 is acylated 
considerably more rapidly than that with the correspond- 
ing (R) or a orientation (cf. 3a > 2a; and also (R)-(+)-4 
> (S)-(-)-4 as discussed below). It also seems apparent 
that a hydroxyl with the C-3-(R) or a orientation is 
acylated more easily than that with the C-343) or @ 
orientation, but selective acylation at a C-5-(S) or /? 
orientation is more important (cf. acylation at C-5 
dominates in the case of 3b). This also rationalizes why 
the selectivities for C-5 acylation are greater for substrate 
3a (Table 4) than for substrate 3b (Table 3), but the 
differences are not large. Only in the case of isomer 2b 
(3R,5R), which possesses the C-54R) configuration (which 
attenuates strongly C-5 acylation) and the C-34R) con- 
figuration (which enhances C-3 acylation), do both hy- 
droxyls work in concert to enhance C-3 acylation. These 
results could be useful in gleaning information about the 
steric requirements of the enzyme active site. 
Resolution of A-Ring Synthon (f)-4. Given the 
difference in reaction times observed for the enantiomers 
2a and 3b as well as 2b and 3a, we examined the 
possibility that CVL could be useful in the kinetic 
resolution of racemic A-ring fragment 4. Recently, this 
laboratory reported that 4-hydroxycyclohexanone (6) 
could be transformed to optically pure (SI-(-1-4, via 
racemic 4 through initial formation of its (lS,l'S) and 
(lR,l'S) carbamates using (SI-naphthyl isocyanate, fol- 
lowed by separation via HPLC and then deprotection of 
the (lS,l'S) carbamate.loa Using CVL, the resolution of 
(f)-4 affording the natural enynol (-)-isomer could be 
nicely effected in only one step (Scheme 6). The reaction 
was carried out at room temperature using CVL with 
vinyl acetate acting as both acylating agent and solvent. 
After 18 h, GC analysis revealing 52% conversion, the 
reaction was stopped and flash chromatography (silica 
gel, 20% EtOAc-hexanes) of the product mixture gave 
the enantiomerically pure (SI-(-1-4 in high yield (97%, 
297% eel5 ). The remaining acetate (99% yield) was 
treated with sodium methoxide to afford (R)-(+)-4 which 
(14) Note that a (down) and ,!? (up) have their usual definitions for 
all of the structures described in this paper except for 1 (Le., vitamin 
D3 and its metabolites). Because vitamin D is typically drawn in its 
more stable nonsteroidal, 6-s-trans conformation, the a's (up) and Ps 
(down) are reversed in orientation for its A ring only. 
(15) Enantiomeric purities indicated as ee 2 97% (*3% by NMR 
analysis) signifies that only one enantiomer was detected even at high 
spectrum amplitude. 
Summary 
Evaluation of the enzymatic acylation of the vitamin 
D A-ring enynes 2a, 2b, 3a, and 3b revealed that CVL 
is the best enzyme for effecting practical levels of regi- 
oselectivity, and the novel finding was made that only 
the cis diol 2b is acylated at the allylic C-3 hydroxyl, the 
other stereoisomers being acylated at C-5. Direct ap- 
plication of this method leads to convenient kinetic 
resolution of fragment (f)-4. An explanation for the 
origin of the selectivity exerted by CVL for the stereoi- 
someric series 2a, 2b, 3a, and 3b awaits further evalu- 
ation. 
Experimental Sectionl6 
General. Subtilisin (type VI11 bacterial), papain, porcine 
pancreatic lipase, PPL, (type I1 crude), and Candida cylin- 
dracea lipase, CCL, (type VI1 crude), were obtained from Sigma 
Chemical Co. Pseudomonas cepacia lipase, PSL, was obtained 
from Amano Pharmaceutical Co. Chromobacterium viscosum 
lipase, CVL, was from Genzyme Co. Candida antarctica lipase, 
CAL SP 435L, was from Novo Nordisk Co. In all cases, crude 
product mixtures were subjected by 'H-NMR integration 
analysis (f3%) to determine percent conversion and relative 
percentages of esterified products as summarized in Tables 
Enzymatic Acetylation of (3S,5R)-2a in Vinyl Acetate. 
To a solution of 2a (10 mg, 0.066 mmol) in vinyl acetate (2.5 
mL) was added one of the following enzymes: 300 mg of CCL, 
PSL, PPL, or papain; 10 mg of CVL; 60 mg of subtilisin; or 45 
mg of CAL. The suspension was shaken at room temperature, 
and the progress of the reaction was followed by TLC until no 
further reaction was apparent. After removal of the enzyme 
by filtration and evaporation of the solvent and 'H-NMR 
analysis, the residual mixture was purified by HPLC (Rainin 
Microsorb, 1 x 25 cm, 5 pm silica gel column, 25% ethyl 
acetatehexanes, 4 mumin) to give monoacetates 8a and 9a. 
The results are summarized in Table 1. 8a: 'H NMR 6 2.02 
(s, 3H, CZ-Me), 2.04 (6,  3H, Me), 2.20 (dd, lH, H6, 'JHH = 17.1, 
3 J ~ ~  = 7.3 Hz), 2.61 (dd, 1H, He, 'JHH = 17.2, 3 J ~ ~  = 4.6 Hz), 
3.10 (s, lH, sp-CHI, 4.25 (m, lH, H3), and 5.14 (m, lH, Hs). 
Additional data used for preparing Table1 are presented in 
the supporting information section.16b In addition, an extended 
survey of these enzymes using various other solvents proved 
less effective: THF (PSL, CVL, CAL), benzene (PSL, CALI, 
pyridine (PSL, substilisin), isopropyl ether (CALI, and dioxane 
(CALI. 
Enzymatic Acylation of 2a with Other Vinyl Esters. 
In a typical procedure, CVL (10 mg) was added to a solution 
of 2a (10 mg, 0.066 mmol) and vinyl ester (0.6 mmol) in THF 
(2.5 mL) or neat vinyl ester (2.5 mL) as solvent as summarized 
in Table 2. The suspension was shaken at 45 "C, and the 
progress of the reaction was followed by TLC. At 100% 
conversion the mixture was filtered and the solvent was 
removed under reduced pressure. After 'H-NMR analysis, the 
crude material was subjected to HPLC (Rainin Microsorb, 1 
1-5.'6b 
(16) (a) For all major products, full spectral data are given in the 
supporting information. Selected 'H-NMR signals are also presented 
in the Experimental Section. The purity of all major isomers or 
intermediates was estimated by a combination of HPLC and NMR 
analysis. The level of purity is indicated by the inclusion of copies of 
'H-NMR spectra and I3C-NMR spectra in the supporting information. 
(b) Minor acylation products, the proportions of which were used in 
the preparation of Tables 1-5, were analyzed as mixtures (using a 
combination of TLC, HPLC, and 'H-NMR analysis) together with the 
major products produced in the enzymatic reactions. Detailed data for 
minor products are also presented at  the end of the supporting 
information section. 
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x 25 cm, 5 pm silica gel column, 25% ethyl acetatehexanes, 4 
mUmin) to  give compounds 8a-d. The 'H-NMR data of 8a 
are given above. 8b: 'H NMR 6 1.13 (t, 3H, Me, 3 J ~ ~  = 7.6 
Hz), 2.03 (s, 3H, Me), 2.20 (dd, lH, He, 'JHH = 17.1, 3 J ~  = 
7.1 Hz), 2.31 (q,2H, MeCH2, 3 J ~ ~  = 7.6 Hz), 2.61 (dd, lH, He, 
'JHH = 17.2, 3 J ~  = 4.9 Hz), 3.09 (s, lH, sp-CH), 4.26 (m, lH, 
H3), and 5.16 (m, lH, H5). 8c: 'H NMR 6 0.94 (t, 3H, Me, 
3 J ~ ~  = 7.4 Hz), 2.02 (s,3H, Me), 2.19 (dd, 1H, He, 'JHH = 17.2, 
3 J ~ ~  = 7.2 Hz), 2.26 (t, 3H, EtCH2, 3 J ~  = 7.4 Hz), 2.60 (dd, 
1H, He, 'JHH = 17.1, 3 J ~ ~  = 4.9 Hz), 3.10 (S, 1H, Sp-CH), 4.25 
(m, lH, H3), and 5.15 (m, lH, H5). 8d  'H NMR 6 2.03 (s, 3H, 
C2-Me), 2.26 (dd, 1H, He, 'JHH = 17.1, 3 J ~ ~  = 7.1 Hz), 2.65 
4.04 (s, 2H, c1c&), 4.30 (t, 1H, H3, 3 J ~ ~  = 4.1 Hz), and 5.25 
(m, lH, H5). Additional data used for preparing Table 2 are 
presented in the supporting information section.leb 
Enzymatic Acylation of (3Ry5S)-3b with Vinyl Esters. 
The procedure parallels that indicated above for obtaining the 
data given in Table 2. However, the results obtained for 3b, 
summarized in Table 3, were for reactions conducted at room 
temperature rather than at  45 "C. The 'H-NMR spectral data 
of loa-d are of course identical to  those of 8a-d given above. 
10e: lH NMR 6 2.07 (s, 3H, Me), 2.38 (dd, lH, He, 'JHH =
17.3, 3 J ~ ~  = 7.0 Hz), 2.74 (dd, 1H, He, 'JHH = 17.2, 3 J ~ ~  = 4.9 
Hz), 3.11 (s, lH, sp-CH), 4.36 (t, lH, H3, 3 J ~ ~  = 4.8 Hz), 5.41 
(apparent q, lH, H5, 3 J ~ ~  = 6.3 Hz), 7.43 (m, 2H, Ph), 7.56 
(m, lH, Ph), and 8.01 (m, 2H, Ph). Additional data used for 
preparing Table 3 are presented in the supporting information 
section.leb 
(5R)- and (SS)-3-Ethynyl-S-hydroxy-2-methyl-2-cyclo- 
hexen-1-one (12a and 12b, respectively). To a mixture of 
the Dess-Martin periodinane reagent (1.5 g, 3.75 mmol) in 
dry acetonitrile (30 mL) was added 2a (380 mg, 2.5 mmol). 
The reaction mixture was stirred at  room temperature for 1 h 
under argon, and then the resulting mixture was diluted with 
ether and washed with a 1:l mixture (v/v) of saturated aqueous 
NazSz03 and NaHC03 solution. The organic layer was then 
dried (MgS04) and evaporated to dryness. The residue was 
purified by flash chromatography on silica gel using 45% ethyl 
acetatehexanes to afford after vacuum drying 310 mg (82%) 
of ketone 12a (or 12b): lH NMR 6 1.99 (s, 3H, Me), 2.48- 
2.65 (dd, 1H, H4, 'JHH = 16.3, 3 J ~ ~  = 8.7 Hz f m, 1H, He), 
2.72-2.90 (dd, lH, Hq, 'JHH = 15.8, 3 J ~ ~  = 4.0 Hz + m, lH, 
He), 3.75 (s, lH, sp-CH), and 4.31 (m, lH, H5). When the same 
procedure was applied to the enantiomer 3b, essentially the 
same result was obtained except the reaction time had to be 
increased to 24 h (possibly due to decreased reactivity of 
oxidant). 
Preparation of Cis Isomers (3R,SR)-2b and (3S,SS)-3a. 
Sodium borohydride (1.3 g, 34 mmol) was added to an ice-cold 
solution of ketone 12a (302 mg, 2 mmol) in methanol (30 mL). 
After stirring for 30 min, the reaction mixture was extracted 
three times with ether and then the combined organic extract 
was dried (MgS04) and concentrated in vacuo. 'H-NMR 
analysis of the crude mixture showed a mixture of diastere- 
oisomers 2a and 2b in the ratio 1:3. The diastereoisomers 
were separated by HPLC (Rainin Dynamax-GOA, 2.14 x 25 
cm, 8 pm silica gel column, 95% ethyl acetatehexanes, 8 mL/ 
min) to give as the major product the cis isomer 2b (207 mg, 
68%). 2b (or 3a): lH NMR 6 1.86 (ddd, lH, H4, 2 J ~  = 14.2, 
lH, H4), 2.25-2.52 (m, 2H, He), 3.02 (br s, lH, OH), 3.10 (s, 
lH, sp-CH), 4.04 (m, lH, H5), and 4.28 (m, lH, H3). The 
enantiomer 12b under identical conditions afforded 3b and 
3a in the same 1:3 ratio, and HPLC purification afforded cis 
isomer 3a also in 68% yield. 
Enzymatic Acetylation of (3Ry5R)-2b and (3S,SS)-3a 
with Vinyl Esters. The procedure was the same as described 
for obtaining the data given in Table 2. The data obtained 
(dd, lH, H6, 'JHH = 17.1, 3 J ~ ~  = 5.0 Hz), 3.11 (s, 1H, Sp-CH), 
3 J ~ ~  = 5.0, 3 J ~ ~  = 2.1 Hz), 2.06 (5, 3H, Me), 2.13-2.24 (m, 
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for 3a and 2b are summarized in Tables 4 and 5, respectively. 
Both 3a and 2b were reacted at room temperature. Com- 
pounds 13a,c-d and 17a,c-d were purified by HPLC (Rainin 
Microsorb, 1 x 25 cm, 5 ,um silica gel column, 20% ethyl 
acetatehexanes, 4 mumin). 13a: lH NMR 6 1.98-2.17 (m, 
8H, 2Me + HJ, 2.33-2.54 (m, 2H, He), 3.11 (s, lH, sp-CH), 
4.09 (m, lH, H3), and 5.19 (m, lH, H5). 13c: 'H NMR 6 0.94 
(t, 3H, Me, 3 J ~ ~  = 7.4 Hz), 1.63 (m, 2H, MeCHd, 2.05 (s, 3H, 
He), 3.10 (8 ,  lH, sp-CH), 4.09 (m, lH, H3), and 5.21 (m, lH, 
H5). 13d 1H NMR 6 2.06 (s, 3H, Me), 3.12 ( 8 ,  lH, sp-CH), 
4.06 (s, 2H, ClCH2), 4.10 (m, lH, H3), and 5.29 (m, lH, H5). 
17a: lH NMR 6 1.90 (s, 3H, C2-Me), 2.09 ( 6 ,  3H, Me), 2.17 
lH, sp-CHI, 4.03 (m, lH, H5), and 5.46 (t, lH, H3, 3 J ~ ~  = 5.7 
2H, MeCHz), 1.89 (s, 3H, CZ-Me), 2.17 (ddd, lH, H4, 'JHH = 
7.4 Hz), 3.15 (s, lH, sp-CH), 4.04 (m, lH, H5), and 5.47 (t, lH, 
H3, 3 J ~ ~  = 5.5 Hz). 17d: 'H NMR 6 1.91 (s, 3H, Me), 2.22 
lH, sp-CH), 4.06 (m, lH, H5), 4.08 (s, 2H, ClCHz), and 5.53 (t, 
lH, H3, 3 J ~  = 5.6 Hz). Additional data used for preparing 
Table 4 and 5 are presented in the supporting information 
section.leb 
(SS)-l-Ethynyl-S-hydroxy-2-methyl-l-cyclohexene I(-)- 
41. To a solution of racemic alcohol 4 (100 mg, 0.734 mmol) 
in vinyl acetate (17 mL) was added CVL (65 mg), and then 
the mixture was shaken at  room temperature. The reaction 
was monitored by GC using a 25 m fused silica glass capillary 
column packed with methyl silicone (helium carrier gas at  16 
psi; injector port temperature 150 "C; detector port tempera- 
ture 200 "C). The temperature of the column was increased 
from 100 to 200 "C at 4 "C/min. The retention times observed 
were 28.7 min for (-)-4 and 34.4 min for 19. The reaction 
was stopped when 52% of the alcohol ( f ) -4  was converted into 
the acetate 19 (approximately 18 h). The reaction mixture was 
filtered and the enzyme washed with methylene chloride. The 
solvent was removed, and the products were separated by flash 
column chromatography using silica gel (20% ethyl acetate/ 
hexanes as eluent) to  afford (574-1-4 (46.5 mg, 97%, 2 97% 
ee15) and the acetate, enriched in (R)-(+)-19 (67.3 mg, 99%, 
94% ee calculated after saponification as indicated below) 
[enantioselectivity, E =- Compound 4 was shown to be 
optically pure by a standard procedure18 by 'H-NMR spectros- 
copy using the chiral shift reagent Eu(hfc)3 (tris[3-((heptafluo- 
ropropy1)hydroxymethylene)-( +)-camphorateleuropium(III)} . 
4: lH NMR 6 1.58-1.72 (m, lH, H4), 1.78-1.96 (m, lH, H4), 
1.89 (s, 3H, Me), 2.04-2.32 (m, 3H, 2H3 +He), 2.41-2.56 (m, 
lH, He), 3.02 (s, lH, sp-CH), and 3.96 (m, lH, H5). 19: 'H 
NMR 6 1.64-1.86 (m, 2H, H4), 1.90 (s, 3H, MeCO), 2.03 (s, 
3H, Me), 2.11-2.30 (m, 3H, 2H3 f He), 2.42-2.57 (m, 1H, H6), 
3.02 (s, lH, sp-CH), and 5.00 (m, lH, H5). 
For the determination of the enantiomeric excess (eel of the 
acetate (R)-(+)-l9, the ester was reacted with sodium meth- 
oxide in methanol. The resulting alcohol (R)-(+)-4 was deter- 
mined to be 94% ee according to 'H-NMR spectroscopy using 
Eu(hfc)3 as described above for (5')-(-)-4. 
Me), 2.27 (t, 2H, EtCH2 , 3 J ~ ~  = 7.5 Hz), 2.33-2.52 (m, 2H, 
(ddd, 1H, Hq, 'JHH = 14.4, 3 J ~ ~  = 5.8, 3 J ~ ~  = 3.0 HZ), 3.15 (S, 
Hz). 1 7 ~ :  'H NMR 6 0.96 (t, 3H, Me, 3 J ~ ~  = 7.4 Hz), 1.67 (m, 
13.2, 3 J ~ ~  = 5.7, 3 J ~ ~  = 3.0 HZ), 2.31 (t, 2H, EtCH2, 3 J ~ ~  = 
(ddd, lH, H4, 'JHH = 13.4, 3 J ~ ~  = 5.9, 3 J ~  = 3.1 Hz), 3.18 (S, 
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